We are live on ! Find out more
HP

HealthInvest Partners Portfolio holdings

AUM $372M
1-Year Est. Return 59.89%
This Fund
S&P 500
This Quarter Est. Return
+7.77%
1 Year Est. Return
+59.89%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$227M
AUM Growth
+$15.7M
Cap. Flow
+$1.83M
Cap. Flow %
0.81%
Top 10 Hldgs %
59.15%
Holding
41
New
5
Increased
10
Reduced
19
Closed
4

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$8.49M
2
GILD icon
Gilead Sciences
GILD
+$7.95M
3
ONC
BeOne Medicines Ltd
ONC
+$3.33M
4
KRYS icon
Krystal Biotech
KRYS
+$2.4M
5
IRTC icon
iRhythm Holdings
IRTC
+$2.18M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$5.94M
2
UNH icon
UnitedHealth
UNH
+$4.82M
3
FOLD
Amicus Therapeutics
FOLD
+$3.08M
4
BSX icon
Boston Scientific
BSX
+$2.21M
5
LLY icon
Eli Lilly
LLY
+$2.05M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.06T
$28.6M 12.62%
34,602
-2,466
-7% -$2.05M
ABBV icon
2
AbbVie
ABBV
$431B
$18.7M 8.25%
89,227
-1,496
-2% -$291K
UNH icon
3
UnitedHealth
UNH
$367B
$13.5M 5.96%
25,782
-9,420
-27% -$4.82M
BSX icon
4
Boston Scientific
BSX
$71.4B
$13.3M 5.89%
132,273
-21,949
-14% -$2.21M
MRK icon
5
Merck
MRK
$317B
$11.5M 5.06%
127,679
+21,952
+21% +$2.05M
TMO icon
6
Thermo Fisher Scientific
TMO
$214B
$11.4M 5.02%
22,857
-2,039
-8% -$1.1M
VRTX icon
7
Vertex Pharmaceuticals
VRTX
$123B
$11.1M 4.88%
22,808
+551
+2% +$257K
COR icon
8
Cencora
COR
$62B
$8.77M 3.87%
31,553
-1,000
-3% -$251K
GILD icon
9
Gilead Sciences
GILD
$162B
$8.63M 3.81%
+76,998
New +$7.95M
SYK icon
10
Stryker
SYK
$129B
$8.56M 3.78%
22,998
-2,662
-10% -$1.01M
NBIX icon
11
Neurocrine Biosciences
NBIX
$16.2B
$8.39M 3.71%
75,881
+8,118
+12% +$1.03M
AMGN icon
12
Amgen
AMGN
$219B
$8.28M 3.66%
26,577
-837
-3% -$247K
ISRG icon
13
Intuitive Surgical
ISRG
$132B
$7.6M 3.36%
+15,345
New +$8.49M
ALKS icon
14
Alkermes
ALKS
$8.11B
$7.09M 3.13%
214,778
-51,721
-19% -$1.69M
ONC
15
BeOne Medicines Ltd
ONC
$36.7B
$6.84M 3.02%
25,141
+14,241
+131% +$3.33M
BBIO icon
16
BridgeBio Pharma
BBIO
$16.2B
$5.23M 2.31%
151,348
+48,316
+47% +$1.63M
EW icon
17
Edwards Lifesciences
EW
$51.5B
$4.33M 1.91%
59,696
-8,600
-13% -$616K
UFPT icon
18
UFP Technologies
UFPT
$2.41B
$4.29M 1.89%
21,259
-1,900
-8% -$460K
KRYS icon
19
Krystal Biotech
KRYS
$9.55B
$4.24M 1.87%
23,491
+14,289
+155% +$2.4M
CAH icon
20
Cardinal Health
CAH
$55.7B
$3.81M 1.68%
27,688
-2,992
-10% -$381K
MIRM icon
21
Mirum Pharmaceuticals
MIRM
$5.74B
$3.48M 1.54%
77,263
-39,429
-34% -$1.86M
DXCM icon
22
DexCom
DXCM
$31.3B
$3.13M 1.38%
45,841
-14,216
-24% -$1.16M
HRMY icon
23
Harmony Biosciences
HRMY
$2.26B
$3.03M 1.34%
91,301
-29,200
-24% -$1.05M
ACLX
24
DELISTED
Arcellx
ACLX
$2.9M 1.28%
44,171
+2,100
+5% +$142K
SLNO
25
DELISTED
Soleno Therapeutics
SLNO
$2.65M 1.17%
37,098
+6,158
+20% +$300K
1
2

Similar funds

KP
Kiltearn Partners Edinburgh, United Kingdom $372M AUM 18.16% 1-Year Est. Return
TCM
Thomist Capital Management Houston, Texas $371M AUM 77.62% 1-Year Est. Return
SAAM
Solus Alternative Asset Management Summit, New Jersey $372M AUM 45.33% 1-Year Est. Return
PAA
Peregrine Asset Advisers Portland, Oregon $371M AUM 41.36% 1-Year Est. Return
PC
Promethos Capital Boston, Massachusetts $372M AUM 23.19% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
GIP
Gavilan Investment Partners Burlingame, California $372M AUM 6.04% 1-Year Est. Return
PC
Prevatt Capital Nassau, Bahamas $371M AUM 9.39% 1-Year Est. Return

HealthInvest Partners's Q1 2025 Portfolio in Review

As of Q1 2025, HealthInvest Partners held 41 positions worth $227M, up 7.4% from $211M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

HealthInvest Partners's Q1 2025 filing shows 5 new, 10 increased, 19 reduced and 4 closed positions. Its largest new stake was Intuitive Surgical: 15,345 shares worth $7.6M. The largest sale was Intra-Cellular Therapies Inc., an estimated $5.94M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • HealthInvest Partners's largest Q1 2025 buy was Intuitive Surgical: 15,345 shares worth $7.6M.
  • HealthInvest Partners added most to BeOne Medicines Ltd in Q1 2025, an estimated $3.33M increase.
  • HealthInvest Partners's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $4.82M.
  • HealthInvest Partners fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $5.94M.
  • HealthInvest Partners's ten largest holdings make up 59% of its $227M portfolio in Q1 2025.
  • HealthInvest Partners opened 5 new positions and closed 4 in Q1 2025.
  • HealthInvest Partners's portfolio value rose 7.4% quarter-over-quarter to $227M.

Based on HealthInvest Partners's 13F filing for Q1 2025, filed 5 May 2025.